908 Devices Inc. (MASS)
NASDAQ (NMS) NASDAQ (NMS) Primary Summary
908 Devices (MASS) Upgraded to Buy: Here's Why
908 Devices (MASS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
908 Devices Looking Better Now (Rating Upgrade)
908 Devices (MASS) delivered strong Q1 results, raising full-year revenue guidance after a strategic acquisition in narcotics detection. Adjusted gross margins improved nearly three percentage points to 57%, and operating cash flow turned positive. The company has a solid balance sheet with nearly $100 million in cash post-acquisition and is debt free, while trading at a reasonable valuation.
908 Devices Inc. (MASS) Reports Q1 Loss, Tops Revenue Estimates
908 Devices Inc. (MASS) came out with a quarterly loss of $0.15 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.22 per share a year ago.
908 Devices Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Robert Bruce Robert Jeffrey Bruce is VP/Secretary at Bruce & Co Inc. | 68,286 | $520,339 | $551,068.02 | $30,729.02 | 5.91% |
 Joseph Castro Nuveen LLC | 101,074 | $454,593.05 | $818,911.66 | $364,318.61 | 80.14% |
| WM Wesley McDowell Meros Investment Management LP | 361,738 | $2.16M | $2.94M | $779,693.58 | 36.02% |
| HFT Hui Fai Tam Caitong International Asset Management Co. Ltd. | 4 | $24 | $30.92 | $6.92 | 28.83% |
| CCW Cassaday & Co. Wealth Management LLC Cassaday & Co. Wealth Management LLC | 71,629 | $627,471 | $553,692.17 | -$73,778.83 | -11.76% |
908 Devices Inc. (MASS) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has 908 Devices Inc. ever had a stock split?
908 Devices Inc. Profile
| Technology Hardware, Storage & Peripherals Industry | Information Technology Sector | Kevin J. Knopp CEO | NASDAQ (NMS) Exchange | 65443P102 CUSIP |
| US Country | 172 Employees | - Last Dividend | - Last Split | 18 Dec 2020 IPO Date |
Overview
908 Devices Inc. is a commercial-stage technology company that specializes in providing handheld and desktop mass spectrometry devices designed for a broad range of applications. The company focuses on developing tools for the analysis of unknown and invisible materials across various sectors, including life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. Established in 2012 and headquartered in Boston, Massachusetts, 908 Devices offers its cutting-edge analytical tools to customers not only in the United States but also in Europe, the Middle East, Africa, the Asia Pacific, and the rest of the Americas.
Products and Services
-
MX908:
This product is a portable, battery-powered mass spectrometry (Mass Spec) device designed for the swift analysis of solid, liquid, vapor, and aerosol materials. Its handheld form factor makes it especially useful in environments where rapid, on-the-spot analysis of unknown substances is critical.
-
Rebel:
Rebel serves as a compact desktop analyzer that delivers real-time insights into the extracellular environment of bioprocesses. It’s engineered for users who need to monitor the biochemical and physical properties of cell culture media in bioprocessing applications.
-
Maverick:
This optical in-line analyzer is aimed at real-time monitoring and control of multiple parameters in mammalian cell cultures, such as glucose, lactate, and total biomass. Maverick also provides process fingerprint data, which can be instrumental in supporting predictive bioprocess modeling on a large scale.
-
Maven and Trace C2:
An online device designed for bioprocess monitoring and control, catering to the needs of bioengineering professionals requiring accurate, real-time data to ensure the optimal conditions of their bioprocesses.
-
ZipChip:
ZipChip is an innovative, plug-and-play, high-resolution separation platform that enhances Mass Spec sample analysis efficiency. It’s intended for users seeking to optimize their mass spectrometry workflows with a high-throughput, easy-to-integrate solution.
